153 related articles for article (PubMed ID: 8194013)
1. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.
Imai M; Hoshi T; Ogawa K
Cancer; 1994 Jun; 73(11):2727-33. PubMed ID: 8194013
[TBL] [Abstract][Full Text] [Related]
2. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
3. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
4. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
5. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing.
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Cancer; 1990 Sep; 66(5):930-5. PubMed ID: 2167148
[TBL] [Abstract][Full Text] [Related]
6. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.
Tomono H; Nimura Y; Aono K; Nakashima I; Iwamoto T; Nakashima N
Am J Gastroenterol; 1996 Jun; 91(6):1211-4. PubMed ID: 8651173
[TBL] [Abstract][Full Text] [Related]
7. [Frequency of K-ras mutation in biliary and pancreatic tumors].
Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures.
Ito R; Tamura K; Ashida H; Nishiwaki M; Nishioka A; Yamamoto Y; Furuyama JI; Utsunomiya J
Int J Oncol; 1998 May; 12(5):1019-23. PubMed ID: 9538122
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma.
Rijken AM; van Gulik TM; Polak MM; Sturm PD; Gouma DJ; Offerhaus GJ
J Surg Oncol; 1998 Jul; 68(3):187-92. PubMed ID: 9701213
[TBL] [Abstract][Full Text] [Related]
10. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections.
Lee JC; Lin PW; Lin YJ; Lai J; Yang HB; Lai MD
J Formos Med Assoc; 1995 Dec; 94(12):719-23. PubMed ID: 8541732
[TBL] [Abstract][Full Text] [Related]
11. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.
Malats N; Porta M; Piñol JL; Corominas JM; Rifà J; Real FX
J Clin Oncol; 1995 Jul; 13(7):1679-86. PubMed ID: 7602358
[TBL] [Abstract][Full Text] [Related]
12. [K-ras gene mutation in gallbladder carcinoma].
Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
[TBL] [Abstract][Full Text] [Related]
13. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer.
Pellegata NS; Losekoot M; Fodde R; Pugliese V; Saccomanno S; Renault B; Bernini LF; Ranzani GN
Anticancer Res; 1992; 12(5):1731-5. PubMed ID: 1444240
[TBL] [Abstract][Full Text] [Related]
14. Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA.
Ridanpää M; Husgafvel-Pursiainen K
Hum Mol Genet; 1993 Jun; 2(6):639-44. PubMed ID: 8353484
[TBL] [Abstract][Full Text] [Related]
15. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
16. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
[TBL] [Abstract][Full Text] [Related]
17. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.
Wattanasirichaigoon S; Tasanakhajorn U; Jesadapatarakul S
J Med Assoc Thai; 1998 May; 81(5):316-23. PubMed ID: 9623030
[TBL] [Abstract][Full Text] [Related]
18. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
19. K-ras oncogene mutation in cancer and precancerous lesions of the gallbladder.
Kim SW; Her KH; Jang JY; Kim WH; Kim YT; Park YH
J Surg Oncol; 2000 Dec; 75(4):246-51. PubMed ID: 11135265
[TBL] [Abstract][Full Text] [Related]
20. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas.
Ohashi K; Tsutsumi M; Nakajima Y; Noguchi O; Okita S; Kitada H; Tsujiuchi T; Kobayashi E; Nakano H; Konishi Y
Jpn J Clin Oncol; 1994 Dec; 24(6):305-10. PubMed ID: 7830335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
